AGP Picks
View all

ATCC Opens Centennial Biomanufacturing Center to Accelerate Biomedical Innovation from Discovery to Delivery

News originally published by

GlobeNewswire

The new center serves as critical infrastructure for the nation, supporting collaboration across the scientific ecosystem and accelerating access to the biological resources that research, product development, and public health response depend on.

Key takeaways

  • ATCC has opened its Centennial Biomanufacturing Center (CBC), a 50,000-square-foot facility that expands U.S.-based production of authenticated biological materials for product development, public health preparedness, and biomedical innovations, including New Approach Methodologies (NAMs).
  • Initial programs at the CBC include validating NAMs to accelerate infectious lung and brain disease research for NIAID. The center will also support NIH outbreak research and USDA work on avian influenza.
  • With high-throughput manufacturing and surge capacity, the CBC gives government, academic, and industry partners a reliable domestic source of essential biomaterials and is expected to create up to 75 jobs in the region.

MANASSAS, Va., Nov. 19, 2026 (GLOBE NEWSWIRE) -- ATCC, the world's largest nonprofit biological resource center, today announced the opening of its Centennial Biomanufacturing Center (CBC), a national resource designed to accelerate the development of critical biological materials, models, and data to help organizations move from discovery to real-world impact.

The center will manufacture, characterize, authenticate, store, and distribute essential biomaterials to support biomedical product development, public health preparedness, and next-generation scientific research.

Located at ATCC's headquarters, the CBC is expected to create up to 75 new full-time jobs and add important capacity to the BioHealth Capital Region, which ranks third nationally among U.S. biopharma clusters.

"ATCC is the trusted foundation for scientific discovery, providing the authenticated biological materials, standards, and expertise that researchers rely on," said Ruth Cheng, PhD, president and CEO of ATCC. "This new center extends that legacy at a pivotal time, giving the nation a reliable domestic source of the materials needed to help our government, academic, and industry partners clear production bottlenecks, accelerate biomedical breakthroughs, and strengthen public health."

Capacity to support large-scale initiatives

The CBC combines high-throughput manufacturing, scalable production, supply chain resilience, and surge capacity in a single facility. The center will produce well-characterized challenge materials, advanced model platforms, and essential reagents, while supporting drug screening and expanding genomic reference data for regulatory use. Together, these capabilities enable faster response to emerging scientific and national priorities.

Among the first programs the CBC will support are producing materials to help the National Institutes of Health (NIH) research and respond to disease outbreaks, as well as developing and testing human-relevant models, including lung and blood-brain barrier models, to advance infectious disease research for the National Institute of Allergy and Infectious Diseases (NIAID). These NAMs could help researchers better understand disease mechanisms and evaluate potential treatments while reducing reliance on traditional animal models.

In addition, the center will support U.S. Department of Agriculture (USDA) initiatives to strengthen biosecurity and advance research on therapeutics and vaccines targeting highly pathogenic avian influenza.

As a cornerstone of the nation's biological preparedness infrastructure, the CBC will also ensure access to the biological materials needed to support warfighters and develop medical countermeasures.

ATCC's authenticated biomaterials, validated reference materials, and ISO 9001-certified quality management system provide researchers with a dependable foundation for reproducible results, helping organizations advance their work with greater confidence and support regulatory readiness. Secure handling procedures, cold-chain logistics, and biosafety compliance further protect material integrity throughout production and distribution.

"When public health threats emerge, the nation's response depends on rapid access to trusted biological materials and the infrastructure to produce them at scale," said Rebecca Bradford, MBA, senior vice president of ATCC Federal Solutions. "ATCC has supported federal programs for decades, and the CBC expands our ability to deliver the materials and expertise that those efforts demand, helping our partners respond to today's challenges while preparing for those we haven't yet encountered."

The center represents an investment of more than $55 million by ATCC, supplemented by federal and state investments, including a C06 Research Facilities Construction Grant from NIH through its Office of Research Infrastructure Programs, a G20 Project grant from NIAID to support research capabilities and pandemic preparedness efforts, and a grant from the Commonwealth's Development Opportunity Fund administered by the Virginia Economic Development Partnership (VEDP).

ATCC marked the opening with a ribbon-cutting ceremony featuring remarks from Virginia Deputy Secretary of Commerce and Trade Stewart Ackerly, Prince William County Chair At-Large Deshundra Jefferson, Cheng, and Bradford.

"When ATCC chose Prince William County in 1998, it invested in the potential of this community," said Jefferson. "Nearly 30 years later, we can see the return on that investment in the jobs created, the scientists attracted, the partnerships built, and an entire innovation district that has grown around a shared commitment to discovery. Today, we're celebrating a new building, but we're also celebrating the people and partnerships that made it possible."

About ATCC

ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cell lines, microorganisms, and associated data for academia, industry, and government. With a history of scientific contributions spanning more than a century, ATCC offers an unmatched combination of being the world's largest and most diverse collection of biological reference materials and data, and is a mission-driven, trusted partner that supports and encourages scientific collaboration. ATCC products, services, partnerships, and people provide the global scientific community with credible, advanced model systems to support complex research and innovations in basic science, drug discovery, translational medicine, and public health. ATCC is a 501(c)3 nonprofit organization headquartered in Manassas, Virginia, with research and technology centers of excellence in Gaithersburg and Germantown, Maryland.

Media Contact:
Samantha Paro
Senior Manager, Corporate Communications & Public Affairs
ATCC
pr@atcc.org


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.